Zynerba Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: 6ZY insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.1%.

Top 25 shareholders own 40.62% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.1%	Harmony Biosciences Holdings, Inc.	7,592,498	€9.3m	0%	no data
8.77%	Beryl Capital Management LLC	4,426,381	€5.4m	0%	2.6%
4.32%	The Vanguard Group, Inc.	2,179,600	€2.7m	0%	no data
1.94%	Armando Anido	976,614	€1.2m	-20.9%	no data
1.47%	BlackRock, Inc.	740,524	€907.0k	-11.7%	no data
1.43%	ETF Managers Group LLC	723,151	€885.8k	0%	0.03%
1.37%	Renaissance Technologies LLC	689,713	€844.8k	21.1%	no data
1.18%	Terri Sebree	596,241	€730.3k	-23.4%	no data
0.77%	Geode Capital Management, LLC	387,346	€474.4k	0%	no data
0.75%	James Fickenscher	378,087	€463.1k	-32.1%	no data
0.49%	Brian Rosenberger	249,559	€305.7k	6.75%	no data
0.45%	Albert Parker	227,018	€278.1k	0%	no data
0.44%	Penserra Capital Management LLC	220,858	€270.5k	0.78%	0.01%
0.25%	Millennium Management LLC	125,835	€154.1k	-72.4%	no data
0.25%	Two Sigma Advisers, LP	124,000	€151.9k	-14.4%	no data
0.24%	State Street Global Advisors, Inc.	119,741	€146.7k	0%	no data
0.23%	Northern Trust Global Investments	115,210	€141.1k	0%	no data
0.17%	Kenneth Jones	85,520	€104.7k	0%	no data
0.16%	John Butler	80,765	€98.9k	144%	no data
0.16%	Bernardo Wealth Planning, LLC	78,578	€96.2k	104%	0.04%
0.15%	Pamela Stephenson	75,778	€92.8k	170%	no data
0.15%	William Federici	75,778	€92.8k	170%	no data
0.15%	Kenneth Moch	75,778	€92.8k	170%	no data
0.15%	Daniel Kisner	75,778	€92.8k	170%	no data
0.15%	Warren Cooper	75,778	€92.8k	170%	no data